Literature DB >> 21277949

Age-dependent effects of initial exposure to nicotine on serotonin neurons.

S J Bang1, K G Commons.   

Abstract

Adolescence is a critical vulnerable period during which exposure to nicotine greatly enhances the possibility to develop drug addiction. Growing evidence suggests that serotonergic (5-HT) neurotransmission may contribute to the initiation and maintenance of addictive behavior. As the dorsal raphe (DR) and median raphe (MnR) nuclei are the primary 5-HT source to the forebrain, the current study tested the hypothesis that there are age-dependent effects of acute nicotine administration on activation of 5-HT neurons within these regions. Both adolescent (Postnatal day 30) and adult (Postnatal day 70) male Sprague-Dawley rats received subcutaneous injection of either saline or nicotine (0.2, 0.4, or 0.8 mg/kg). Subsequently, the number of 5-HT cells that were double-labeled for Fos and tryptophan hydroxylase was counted in seven subregions within the DR and the entire MnR. The results show that acute nicotine injection induces Fos expression in 5-HT neurons in a region-specific manner. In addition, adolescents show broader regional activations at either a lower (0.2 mg/kg) and a higher (0.8 mg/kg) dose of nicotine, displaying a unique U-shape response curve across doses. In contrast, 5-HT cells with activated Fos expression were restricted to fewer regions in adults, and the patterns of expression were more consistent across doses. The results reveal dose-dependent effects of nicotine during adolescence with apparent sensitization at different ends of the dosage spectrum examined compared to adults. These data indicate that initial exposure to nicotine may have unique effects in adolescence on the ascending 5-HT system, with the potential for consequences on the affective-motivational qualities of the drug and the subsequent propensity for repeated use.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277949      PMCID: PMC3059362          DOI: 10.1016/j.neuroscience.2011.01.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  58 in total

Review 1.  A review of central 5-HT receptors and their function.

Authors:  N M Barnes; T Sharp
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

2.  Projections of the median raphe nucleus in the rat.

Authors:  R P Vertes; W J Fortin; A M Crane
Journal:  J Comp Neurol       Date:  1999-05-17       Impact factor: 3.215

3.  Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.

Authors:  J K Abrams; P L Johnson; A Hay-Schmidt; J D Mikkelsen; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling.

Authors:  Theodore A Slotkin; Charlotte A Tate; Mandy M Cousins; Frederic J Seidler
Journal:  Neuropsychopharmacology       Date:  2005-12-07       Impact factor: 7.853

5.  Increased nicotine self-administration following prenatal exposure in female rats.

Authors:  Edward D Levin; Susan Lawrence; Ann Petro; Kofi Horton; Frederic J Seidler; Theodore A Slotkin
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

6.  Presynaptic nicotinic receptors facilitate monoaminergic transmission.

Authors:  X Li; D G Rainnie; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

7.  Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine.

Authors:  Megan J Shram; Douglas Funk; Zhaoxia Li; Anh D Lê
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

8.  Age of smoking initiation: implications for quitting.

Authors:  J Chen; W J Millar
Journal:  Health Rep       Date:  1998       Impact factor: 4.796

9.  Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons.

Authors:  Jacob H Hollis; Andrew K Evans; Kimberly P E Bruce; Stafford L Lightman; Christopher A Lowry
Journal:  Brain Behav Immun       Date:  2006-03-22       Impact factor: 7.217

Review 10.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

View more
  4 in total

1.  Shifting topographic activation and 5-HT1A receptor-mediated inhibition of dorsal raphe serotonin neurons produced by nicotine exposure and withdrawal.

Authors:  Robin Sperling; Kathryn G Commons
Journal:  Eur J Neurosci       Date:  2011-04-19       Impact factor: 3.386

Review 2.  Nicotine and the adolescent brain.

Authors:  Menglu Yuan; Sarah J Cross; Sandra E Loughlin; Frances M Leslie
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

Review 3.  Unique, long-term effects of nicotine on adolescent brain.

Authors:  Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2020-07-30       Impact factor: 3.533

4.  Chronic nicotine exposure attenuates the effects of Δ9 -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats.

Authors:  Laurie A Manwell; Tanya Miladinovic; Elana Raaphorst; Shadna Rana; Sarah Malecki; Paul E Mallet
Journal:  Brain Behav       Date:  2019-10-03       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.